EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa

Ronald Kiguba iD, Sten Olsson iD, Catriona Waitt iD

British Journal of Clinical Pharmacology · 2023-02 · 89 (2) · 491-509

DOI: 10.1111/bcp.15193 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 09.02.2022. Verfasst von Ronald Kiguba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Developing Countries, Drug-Related Side Effects and Adverse Reactions, Pharmacovigilance. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low‐ and middle‐income countries (LMIC) face unique challenges with regard to the establishment of robust pharmacovigilance systems capable of generating data to inform healthcare policy and practice. These include the limited integration and reliability of pharmacovigilance systems across LMIC despite recent efforts to harmonize pharmacovigilance rules and regulations in several regional economic communities. There are particular challenges relating to the need to translate reporting tools into numerous local languages and the low numbers of healthcare providers relative to number of patients, with very short consultation times. Additional factors frequent in LMIC include high uptake of herbal and traditional medication, mostly by self‐medication; disruptive political conflicts jeopardizing fragile systems; and little or no access to drug utilization data, which makes it difficult to reliably estimate the true risks of medicines use. Pharmacovigilance activities are hindered by the scarcity of well‐trained personnel with little or no budgetary support from national governments; high turnover of pharmacovigilance staff whose training involves a substantial amount of resources; and little awareness of pharmacovigilance among healthcare workers, decision makers and consumers. Furthermore, little collaboration between public health programmes and national medicines regulatory authorities coupled with limited investment in pharmacovigilance activities, especially during mass drug administration for neglected tropical diseases and mass vaccinations, produces major challenges in establishing a culture where pharmacovigilance is systematically embedded. Very low spontaneous reporting rates with poor quality reports hinders robust signal detection analyses. This review summarises the specific challenges and areas of progress in pharmacovigilance in LMIC with special focus on the situation in Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsDeveloping CountriesDrug-Related Side Effects and Adverse ReactionsPharmacovigilanceHumansAfricaHealth PersonnelReproducibility of Results

Stichwörter der Autor:innen

Africamedicines safetypharmacovigilance

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, Makerere University, Kampala, Uganda.
  • Pharmacovigilance Consulting, Uppsala, Sweden.
  • Department of Pharmacology and Therapeutics, University of Liverpool, UK.
  • Infectious Diseases Institute, Makerere University College of Health Sciences, Uganda.

ORCID-Profile: Ronald Kiguba, Sten Olsson, Catriona Waitt

Förderung

  • Wellcome

Zitieren

APA

Kiguba, R., Olsson, S., & Waitt, C. (2023). Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa. British Journal of Clinical Pharmacology, 89(2), 491-509. https://doi.org/10.1111/bcp.15193

Vancouver

Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa. British Journal of Clinical Pharmacology. 2023;89(2):491-509. doi:10.1111/bcp.15193

BibTeX
@article{Kiguba2023,
  author = {Kiguba, Ronald and Olsson, Sten and Waitt, Catriona},
  title = {Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  volume = {89},
  number = {2},
  pages = {491--509},
  doi = {10.1111/bcp.15193}
}
Kostenlos starten →